Suppr超能文献

术前非刺激肾上腺静脉采样指数预测单侧原发性醛固酮增多症肾上腺切除术的结果。

Preoperative non-stimulated adrenal venous sampling index for predicting outcomes of adrenalectomy for unilateral primary aldosteronism.

机构信息

Division of Nephrology, Department of Medicine, Kaohsiung Veterans General Hospital, and National Yang-Ming University, School of Medicine, Taiwan; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Department of Medical Imaging, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

出版信息

J Formos Med Assoc. 2020 Jul;119(7):1185-1192. doi: 10.1016/j.jfma.2020.04.016. Epub 2020 May 5.

Abstract

BACKGROUND/PURPOSE: The aim of this study was to predict outcomes of adrenalectomy for unilateral primary aldosteronism (PA) using non-stimulated adrenal venous sampling (AVS) indices and the standardized Primary Aldosteronism Surgical Outcome (PASO) criteria.

METHODS

Patients with unilateral PA who underwent adrenalectomy based on non-stimulated AVS and had follow-up data regarding surgical outcomes between 2011 and 2016 were enrolled. Demographic data and non-stimulated AVS indices, including lateralization index (LI) and contralateral suppression, were collected for analysis.

RESULTS

This study included 54 patients who underwent adrenalectomy. Clinical and biochemical outcomes were evaluated in all patients and in 52 (96.3%) patients, respectively. Complete clinical and biochemical success was achieved in 31 (57.4%) of 54 patients and 42 (80.8%) of 52 patients, respectively. An LI > 4 was significantly associated with complete clinical and biochemical success (OR = 4.30, 95% CI 1.18-15.68, p = 0.03, and OR = 7.55, 95% CI 1.28-44.47, p = 0.03, respectively). Contralateral suppression was an independent predictor of complete biochemical success (OR = 17.27, 95% CI 1.95-153.21, p = 0.01).

CONCLUSION

Non-stimulated AVS indices including LI and contralateral suppression are reliable preoperative determinants for predicting the outcomes of adrenalectomy in patients with unilateral PA. Our findings provide more evidence and confidence to clinicians when applying non-stimulated AVS to determine PA treatment.

摘要

背景/目的:本研究旨在通过非刺激肾上腺静脉采样(AVS)指数和标准化原发性醛固酮增多症手术结局(PASO)标准来预测单侧原发性醛固酮增多症(PA)患者肾上腺切除术的结果。

方法

纳入 2011 年至 2016 年间基于非刺激 AVS 行肾上腺切除术且有手术结局随访数据的单侧 PA 患者。收集人口统计学数据和非刺激 AVS 指数,包括侧化指数(LI)和对侧抑制。

结果

本研究共纳入 54 例接受肾上腺切除术的患者。所有患者均进行临床和生化结局评估,其中 52 例(96.3%)患者分别进行评估。54 例患者中,31 例(57.4%)完全达到临床和生化成功,52 例患者中,42 例(80.8%)完全达到生化成功。LI>4 与完全临床和生化成功显著相关(OR=4.30,95%CI 1.18-15.68,p=0.03 和 OR=7.55,95%CI 1.28-44.47,p=0.03)。对侧抑制是完全生化成功的独立预测因素(OR=17.27,95%CI 1.95-153.21,p=0.01)。

结论

包括 LI 和对侧抑制在内的非刺激 AVS 指数是预测单侧 PA 患者肾上腺切除术结果的可靠术前决定因素。我们的研究结果为临床医生应用非刺激 AVS 来确定 PA 治疗提供了更多的证据和信心。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验